This is module three of six core modules for the Biomarker Testing Navigation Certificate program. This online, interactive module discusses following standard cancer biomarker testing protocols.
To enroll for free in the full Biomarker Testing Navigation Certificate program, click here:
Course topics include:
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Learning Objectives
Upon completion of this activity, you will be able to:
-
Explain the role of standardized cancer biomarker testing
-
Recognize clinical practice guidelines for cancer biomarker testing
-
Identify predictive cancer biomarkers for advanced non-small cell lung, colorectal, and other cancers with recommended testing protocols
-
Apply cancer biomarker testing to clinical cases
-
Analyze the current challenges and emerging trends impacting cancer biomarker testing
Faculty
Michelle Shiller, DO
Medical Director, Cancer Genetics, Baylor Sammons Cancer Center
Dallas, TX
Faculty Disclosures
All Financial relationships for Dr. Shiller have been mitigated.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
ASCP designates this activity for a maximum of .5 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CMLE credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must participate in the online activity. CMLE certificates will be provided online.
Commercial Support
This activity is supported by a sponsorship from AstraZeneca.